Q. Shao

1.2k total citations
31 papers, 914 citations indexed

About

Q. Shao is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Q. Shao has authored 31 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Q. Shao's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (6 papers) and Cancer-related molecular mechanisms research (4 papers). Q. Shao is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (6 papers) and Cancer-related molecular mechanisms research (4 papers). Q. Shao collaborates with scholars based in China, United States and Switzerland. Q. Shao's co-authors include Wolfgang Kothny, Valentina Lukashevich, Anja Schweizer, Per‐Henrik Groop, S. Dejager, James E. Foley, Wenguang Ye, Mingxin Zhang, Suna Zhou and Yuhong Qi and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and Chemico-Biological Interactions.

In The Last Decade

Q. Shao

29 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Q. Shao China 14 595 409 249 207 110 31 914
Yuta Takagaki Japan 10 211 0.4× 293 0.7× 154 0.6× 124 0.6× 86 0.8× 15 711
Debi K. Swertfeger United States 16 212 0.4× 306 0.7× 253 1.0× 131 0.6× 168 1.5× 23 773
Kyoko Nitta Japan 9 214 0.4× 245 0.6× 140 0.6× 79 0.4× 62 0.6× 14 588
Xuesong Guan United States 11 1.3k 2.2× 612 1.5× 582 2.3× 279 1.3× 54 0.5× 21 1.7k
Yoshiki Higashijima Japan 14 198 0.3× 362 0.9× 113 0.5× 71 0.3× 69 0.6× 24 729
Toshie Iijima Japan 13 657 1.1× 279 0.7× 338 1.4× 113 0.5× 37 0.3× 35 967
Junichiro Tohyama United States 14 245 0.4× 240 0.6× 381 1.5× 76 0.4× 166 1.5× 17 790
Siyer Roohani Germany 11 234 0.4× 176 0.4× 147 0.6× 52 0.3× 33 0.3× 37 614
Essa Y. Baitei Saudi Arabia 18 384 0.6× 327 0.8× 60 0.2× 161 0.8× 74 0.7× 27 743
Sumeet A. Khetarpal United States 15 292 0.5× 214 0.5× 292 1.2× 45 0.2× 143 1.3× 24 784

Countries citing papers authored by Q. Shao

Since Specialization
Citations

This map shows the geographic impact of Q. Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q. Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q. Shao more than expected).

Fields of papers citing papers by Q. Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Q. Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q. Shao. The network helps show where Q. Shao may publish in the future.

Co-authorship network of co-authors of Q. Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Q. Shao. A scholar is included among the top collaborators of Q. Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Q. Shao. Q. Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaomin, et al.. (2025). Allogeneic composite amniotic membrane in tympanic membrane repair: a randomized parallel controlled study. Acta Oto-Laryngologica. 145(5). 424–429. 1 indexed citations
2.
Chen, Menghui, Zhiguo Hou, Yao Qin, et al.. (2024). Pirfenidone in the Treatment of Radiation-Induced Lung Injury: A Randomized, Controlled, Multicenter Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S14–S14. 2 indexed citations
3.
Zhao, Qianqian, et al.. (2023). Epidemiology of and factors associated with overall survival for patients with head and neck adenoid cystic carcinoma. Journal of Cancer Research and Clinical Oncology. 149(15). 14071–14080. 2 indexed citations
4.
Gao, Ke, Q. Shao, Yuhong Qi, et al.. (2023). DNA repair pathways-targeted cyclovirobuxine inhibits castration-resistant prostate cancer growth by promoting cell apoptosis and cycle arrest. Translational Oncology. 35. 101708–101708. 4 indexed citations
5.
Zhu, Siying, et al.. (2023). CDK2 and CDK4 targeted liensinine inhibits the growth of bladder cancer T24 cells. Chemico-Biological Interactions. 382. 110624–110624. 4 indexed citations
6.
7.
Yu, De‐Quan, et al.. (2021). Breast Cancer Subtypes and Mortality of Breast Cancer Patients With Brain Metastasis at Diagnosis: A Population-Based Study. INQUIRY The Journal of Health Care Organization Provision and Financing. 58. 2846649364–2846649364. 4 indexed citations
8.
9.
Wang, Yuqi, Zubiao Niu, Lülin Zhou, et al.. (2021). Subtype-Based Analysis of Cell-in-Cell Structures in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 670051–670051. 17 indexed citations
10.
Yang, Haixia, et al.. (2016). Role of HOXD10 in radiosensitivity of cholangiocarcinoma cells. Tumori. 36(9). 986–993. 1 indexed citations
11.
Zhou, Suna, Wenguang Ye, Juan Ren, et al.. (2015). MicroRNA-381 increases radiosensitivity in esophageal squamous cell carcinoma.. PubMed. 5(1). 267–77. 34 indexed citations
12.
Guo, Juan, et al.. (2014). The prevention of radiation-induced DNA damage and apoptosis in human intestinal epithelial cells by salvianic acid A. SHILAP Revista de lepidopterología. 7(3). 274–285. 17 indexed citations
13.
Zhang, Yanjun, Juan Guo, Rui Li, et al.. (2013). AB01. Evaluation of stereotactic radiotherapy in 100 elder gastric carcinoma cases.
14.
Qi, Yuhong, et al.. (2013). Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: Association with the risk of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 38(2). 172–180. 15 indexed citations
15.
Zhou, Suna, Wenguang Ye, Q. Shao, et al.. (2013). Prognostic significance of XIAP and NF-κB expression in esophageal carcinoma with postoperative radiotherapy. World Journal of Surgical Oncology. 11(1). 288–288. 31 indexed citations
16.
Lukashevich, Valentina, Anja Schweizer, Q. Shao, Per‐Henrik Groop, & Wolfgang Kothny. (2011). Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24‐week randomized placebo‐controlled trial. Diabetes Obesity and Metabolism. 13(10). 947–954. 113 indexed citations
17.
Shao, Q., et al.. (2011). Three-Dimensional Conformal Radiation Therapy of Spontaneous Benign Prostatic Hyperplasia in Canines. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(5). 225–235. 1 indexed citations
18.
Schweizer, Anja, S. Dejager, James E. Foley, Q. Shao, & Wolfgang Kothny. (2010). Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trials. Diabetes Obesity and Metabolism. 13(1). 55–64. 79 indexed citations
19.
Fonseca, Vivian, Michelle A. Baron, Q. Shao, & S. Dejager. (2008). Sustained Efficacy and Reduced Hypoglycemia during One Year of Treatment with Vildagliptin Added to Insulin in Patients with Type 2 Diabetes Mellitus. Hormone and Metabolic Research. 40(6). 427–430. 70 indexed citations
20.
Göke, Burkhard, Kenneth S. Hershon, Douglas A. Kerr, et al.. (2008). Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naïve Patients with Type 2 Diabetes: Comparison with Metformin. Hormone and Metabolic Research. 40(12). 892–895. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuta Takagaki Breakdown of academic impact, for papers by Debi K. Swertfeger Breakdown of academic impact, for papers by Kyoko Nitta Breakdown of academic impact, for papers by Xuesong Guan Breakdown of academic impact, for papers by Yoshiki Higashijima Breakdown of academic impact, for papers by Toshie Iijima Breakdown of academic impact, for papers by Junichiro Tohyama Breakdown of academic impact, for papers by Siyer Roohani Breakdown of academic impact, for papers by Essa Y. Baitei Breakdown of academic impact, for papers by Sumeet A. Khetarpal
Rankless by CCL
2026